Designing an Artificial Golgi reactor to achieve targeted glycosylation of monoclonal antibodies (2016)
Attributed to:
Frontier Manufacturing: Scaling up synthetic biology
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/aic.15388
Publication URI: http://dx.doi.org/10.1002/aic.15388
Type: Journal Article/Review
Parent Publication: AIChE Journal
Issue: 9